Newsroom

Nearly 27.4 million people across the country have no health insurance, and about 147 million more have inadequate health insurance, according to an analysis by the Kaiser Family Foundation in 2017. This means that more than half of the American population experiences some form of health care insecurity and therefore may not be receiving proper medical care. To alleviate this problem, the 340B program was created in 1992 to aid vulnerable and uninsured Americans by reducing health care costs.

There’s an old story about a town that had a mouse problem. The town officials offered its residents 5 cents for every mouse tail they brought in as a way to incentivize the townspeople in the battle against infestation.

The Alliance for Integrity and Reform of 340B (AIR340B) issued the following statement regarding the 2020 Outpatient Prospective Payment System & Ambulatory Surgical Center Price Transparency Requirements for Hospitals to Make Standard Charges Public final rule.

As our leaders in Washington, D.C., seek ways to lower health care costs and increase access to quality care for all, they need to strengthen and protect programs that have a successful track record of bringing quality, low-cost coverage to millions.

According to a new report, Left Behind: An Analysis of Charity Care Provided by Hospitals Enrolled in the 340B Discount Program, nearly two out of three 340B hospitals are consistently providing below average rates of charity care, which is defined as free or discounted hospital care provided to patients who meet certain income requirements.

Federally sponsored health care programs often start with the best intentions and have the potential to be successful in reducing the cost of quality health care across the nation.

The 340B Drug Pricing Program was created by Congress in 1992 to allow nonprofit healthcare providers with limited resources to ensure access to medicines for uninsured patients with acute and chronic health conditions and disorders.

Sen. Bill Cassidy (R-LA) urged stakeholders at a 340B reform conference to help him find a Democrat to cosponsor legislation to change the drug discount program if they want it to move forward, while Rep. Buddy Carter (R-GA) said he’s not optimistic the program will be dealt with this Congress. Cassidy said that legislation is needed to permanently change the program since CMS’ effort to change reimbursement rates for 340B drugs was knocked down by the courts. “We are not...